Original Literature | Model OverView |
---|---|
Publication
Title
Innate immune responses: crosstalk of signaling and regulation of genetranscription.
Affiliation
College of Life Sciences, Wuhan University, Wuhan 430072, China.
Abstract
Innate immune responses to pathogens such as bacteria and viruses are triggeredby recognition of specific structures of invading pathogens calledpathogen-associated molecular patterns (PAMPs) by cellular pattern recognitionreceptors (PRRs) that are located at plasma membrane or inside cells.Stimulation of different PAMPs activates Toll-like receptor (TLR)-dependent and-independent signaling pathways that lead to activation of transcription factorsnuclear factor-kappaB (NF-kappaB), interferon regulatory factor 3/7 (IRF3/7)and/or activator protein-1 (AP-1), which collaborate to induce transcription ofa large number of downstream genes. This review focuses on the rapid progressthat has recently improved our understanding of the crosstalk among the pathwaysand the precise regulation of transcription of the downstream genes.
PMID
16753195
|
Entity
Process
NF-kappaB
--
MO000000058
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m27
10
infinite
0
TRANSPATH | MO000000058 |
--
IKK-beta
--
MO000000211
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m182
10
infinite
0
InterPro | IPR000719 |
TRANSPATH | MO000000211 |
--
TRAF6
--
MO000000212
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m183
10
infinite
0
InterPro | IPR001841 |
TRANSPATH | MO000000212 |
--
TNF-alpha
--
MO000000289
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m230
10
infinite
0
InterPro | IPR003636 |
TRANSPATH | MO000000289 |
--
IRF-3
--
MO000007694
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m977
10
infinite
0
InterPro | IPR008984 |
TRANSPATH | MO000007694 |
--
IRF-7
--
MO000007702
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m980
10
infinite
0
TRANSPATH | MO000007702 |
--
TAK1
--
MO000016574
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m1573
10
infinite
0
InterPro | IPR000719 |
TRANSPATH | MO000016574 |
--
csml-variable:Double
m332813
10
infinite
0
Affymetrix | 209124_at |
Ensembl | ENSG00000172936 |
HGNC | MYD88 |
InterPro | IPR000157 |
OMIM | 602170 |
Proteome | HumanPSD/MYD88 |
RefSeq | NM_002468 |
TRANSPATH | MO000019348 |
Unigene | Hs.82116 |
UniProt | Q99836 |
--
dsRNA
--
MO000022224
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m119368
10
infinite
0
TRANSPATH | MO000022224 |
--
dsRNA:TLR3
--
MO000041446
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m19314
10
infinite
0
TRANSPATH | MO000041446 |
--
--
e1
cso30:c:EntityBiologicalCompartment
cso30:i:CC_PlasmaMembrane
--
--
--
csml-variable:Double
m1
0
infinite
0
--
--
e10
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Cytosol
--
--
--
csml-variable:Double
m10
0
infinite
0
--
--
e11
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Endosome
--
--
--
csml-variable:Double
m11
0
infinite
0
--
--
e12
cso30:c:EntityBiologicalCompartment
cso30:i:CC_EndosomeLumen
--
--
--
csml-variable:Double
m12
0
infinite
0
--
csml-variable:Double
m13
0
infinite
0
--
TLR9:CpGmotif
--
e14
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m14
0
infinite
0
--
CpGmotif:TLR9:MyD88
--
e15
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m15
0
infinite
0
--
CpGmotif:TLR9:MyD88:IRAK-4
--
e16
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m16
0
infinite
0
--
CpGmotif:TLR9:MyD88:IRAK-4:IRAK
--
e17
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m17
0
infinite
0
--
CpGmotif:TLR9:MyD88:IRAK-4:IRAK{p}
--
e18
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m18
0
infinite
0
--
CpGmotif:TLR9:MyD88:IRAK-4:IRAK{p}{p}
--
e19
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m19
0
infinite
0
--
--
e2
cso30:c:EntityBiologicalCompartment
cso30:i:CC_PlasmaMembrane_ExternalSideOfPlasmaMembrane_
--
--
--
csml-variable:Double
m2
0
infinite
0
--
CpGmotif:TLR9:MyD88:IRAK-4:IRAK{p}{p}:TRAF6
--
e20
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m20
0
infinite
0
--
IRAK:TRAF6
--
e21
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m21
0
infinite
0
--
TAK1:TAB1:TAB2
--
e22
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m22
0
infinite
0
--
IRAK:TRAF6:TAK1:TAB1:TAB2
--
e23
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m23
0
infinite
0
--
IRAK:TRAF6:TAK1{p}:TAB1:TAB2
--
e24
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m24
0
infinite
0
--
NF-kappaB{active}
--
e27
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m28
10
infinite
0
TRANSPATH | MO000000058 |
--
--
e3
cso30:c:EntityBiologicalCompartment
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
--
--
csml-variable:Double
m3
0
infinite
0
--
Nod1:PGN
--
e30
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m32
0
infinite
0
--
Nod2:PGN
--
e31
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m33
0
infinite
0
--
DDX58:dsRNA
--
e33
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m35
0
infinite
0
--
IFIH1:dsRNA
--
e34
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m36
0
infinite
0
--
DDX58:dsRNA:MAVS
--
e35
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m37
0
infinite
0
--
GR
--
e36
cso30:c:Protein
cso30:i:CC_Nucleoplasm
--
--
csml-variable:Double
m38
0
infinite
0
--
Ligand
--
e37
cso30:c:Protein
cso30:i:CC_Nucleoplasm
--
--
csml-variable:Double
m39
0
infinite
0
--
GR:Ligand
--
e38
cso30:c:Complex
cso30:i:CC_Nucleoplasm
--
csml-variable:Double
m40
0
infinite
0
--
Scyb9
--
e39
cso30:c:mRNA
cso30:i:CC_Nucleoplasm
--
--
csml-variable:Double
m41
0
infinite
0
--
--
e4
cso30:c:EntityBiologicalCompartment
cso30:i:CC_PlasmaMembrane_InternalSideOfPlasmaMembrane_
--
--
--
csml-variable:Double
m4
0
infinite
0
--
IP10
--
e40
cso30:c:mRNA
cso30:i:CC_Nucleoplasm
--
csml-variable:Double
m42
0
infinite
0
--
dsRNA:TLR3:TRIF
--
e41
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m43
0
infinite
0
--
dsRNA:TLR3:TRIF:TBK1
--
e42
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m44
0
infinite
0
--
dsRNA:TLR3:TRIF:IKK-i
--
e43
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m45
0
infinite
0
--
dsRNA:TLR3:TRIF:IKK-beta
--
e44
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m46
0
infinite
0
--
dsRNA:TLR3:TRIF:TRAF6
--
e45
cso30:c:Complex
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m47
0
infinite
0
--
IRF-3{p}
--
e46
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m48
10
infinite
0
InterPro | IPR008984 |
TRANSPATH | MO000007694 |
--
IRF-7{p}
--
e47
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m49
10
infinite
0
TRANSPATH | MO000007702 |
--
IFIH1:dsRNA:MAVS
--
e48
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m63
0
infinite
0
--
LPS:TLR4:TRAM
--
e49
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m64
0
infinite
0
--
LPS:TLR4
--
e5
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m5
0
infinite
0
--
--
e50
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearEnvelopeLumen
--
--
--
csml-variable:Double
m50
0
infinite
0
--
--
e51
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearPore
--
--
--
csml-variable:Double
m51
0
infinite
0
--
--
e52
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearInnerMembrane
--
--
--
csml-variable:Double
m52
0
infinite
0
--
--
e53
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearLumen
--
--
--
csml-variable:Double
m53
0
infinite
0
--
--
e54
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearOuterMembrane
--
--
--
csml-variable:Double
m54
0
infinite
0
--
--
e55
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Nucleus
--
--
--
csml-variable:Double
m55
0
infinite
0
--
--
e56
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Nucleoplasm
--
--
--
csml-variable:Double
m56
0
infinite
0
--
--
e57
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearBody
--
--
--
csml-variable:Double
m57
0
infinite
0
--
--
e58
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Nucleolus
--
--
--
csml-variable:Double
m58
0
infinite
0
--
--
e59
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearEnvelope
--
--
--
csml-variable:Double
m59
0
infinite
0
--
--
e6
cso30:c:EntityBiologicalCompartment
cso30:i:CC_EndosomeMembrane
--
--
--
csml-variable:Double
m6
0
infinite
0
--
--
e60
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Chromatin
--
--
--
csml-variable:Double
m60
0
infinite
0
--
--
e61
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearChromosome
--
--
--
csml-variable:Double
m61
0
infinite
0
--
--
e62
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearCentromere
--
--
--
csml-variable:Double
m62
0
infinite
0
--
LPS:TLR4:TRAM:TRIF
--
e63
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m65
0
infinite
0
--
LPS:TLR4:TRAM:TRIF:IKK-i
--
e64
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m66
0
infinite
0
--
LPS:TLR4:TRAM:TRIF:TBK1
--
e65
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m67
0
infinite
0
--
LPS:TLR4:TRAM:TRIF:IKK-beta
--
e66
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m68
0
infinite
0
--
RIP1
--
e67
cso30:c:Protein
cso30:i:CC_Cytosol
--
csml-variable:Double
m69
0
infinite
0
--
LPS:TLR4:TRAM:TRIF:RIP1
--
e68
cso30:c:Complex
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m70
0
infinite
0
--
dsRNA:TLR3:TRIF:RIP1
--
e69
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m71
0
infinite
0
--
--
e7
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Cell
--
--
--
csml-variable:Double
m7
0
infinite
0
--
DDX58:dsRNA:MAVS:RIP1:FADD
--
e70
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m72
0
infinite
0
--
IFIH1:dsRNA:MAVS:RIP1:FADD
--
e71
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m73
0
infinite
0
--
LPS:TLR4:TIRAP
--
e72
cso30:c:Complex
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
csml-variable:Double
m74
0
infinite
0
--
LPS:TLR4:TIRAP:MyD88
--
e73
cso30:c:Complex
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
csml-variable:Double
m75
0
infinite
0
--
LPS:TLR4:TIRAP:MyD88:IRAK-4
--
e74
cso30:c:Complex
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
csml-variable:Double
m76
0
infinite
0
--
LPS:TLR4:TIRAP:MyD88:IRAK-4:IRAK
--
e75
cso30:c:Complex
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
csml-variable:Double
m77
0
infinite
0
--
LPS:TLR4:TIRAP:MyD88:IRAK-4:IRAK{p}
--
e76
cso30:c:Complex
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
csml-variable:Double
m78
0
infinite
0
--
LPS:TLR4:TIRAP:MyD88:IRAK-4:IRAK{p}{p}
--
e77
cso30:c:Complex
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
csml-variable:Double
m79
0
infinite
0
--
LPS:TLR4:TIRAP:MyD88:IRAK-4:IRAK{p}{p}:TRAF6
--
e78
cso30:c:Complex
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
csml-variable:Double
m80
0
infinite
0
--
DDX58:dsRNA:MAVs:TRAF6
--
e79
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m81
0
infinite
0
--
--
e8
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Cell_WithoutCellWall_
--
--
--
csml-variable:Double
m8
0
infinite
0
--
IFIH1:dsRNA:MAVS:TRAF6
--
e80
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m82
0
infinite
0
--
IFIH1:dsRNA:MAVS:TRAF6:TAK1
--
e81
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m83
0
infinite
0
--
DDX58:dsRNA:MAVs:TRAF6:TAK1
--
e82
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m84
0
infinite
0
--
TNF-alphaR
--
e83
cso30:c:Protein
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
--
csml-variable:Double
m85
0
infinite
0
--
TNF-alpha:TNF-alphaR
--
e84
cso30:c:Complex
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
csml-variable:Double
m86
0
infinite
0
--
cytokines
--
e85
cso30:c:mRNA
cso30:i:CC_NuclearChromosome
--
csml-variable:Double
m87
0
infinite
0
--
--
e9
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Cytoplasm
--
--
--
csml-variable:Double
m9
0
infinite
0
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c1 : 1
stoichiometry:c2 : 1
stoichiometry:c3 : 1
m155666*m3961*0.1
nodelay
--
0
PMID:16753195,9851930,11607032 For example, lipopolysaccharide (LPS), a common structure of the cell wall of Gram-negative bacteria, is recognized by TLR4 ; double-stranded RNA (dsRNA), which has long been considered a viral PAMP, triggers TLR3 signaling PMID: 16753195,9851930 LPS has long been identified as ligand for TLR4 via analysis of mice with a point mutation in the gene encoding TLR4
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c26 : 1
stoichiometry:c27 : 1
stoichiometry:c28 : 1
m20*0.1
nodelay
--
0
PMID: 16753195,15229469 The IRAK1?TRAF6 complex then disassociates from the receptor and interacts with another complex consisting of TAK1, TAB1 and TAB2, followed by the phosphorylation and activation of TAK1
p11
p11
cso30:i:ME_Binding
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c29 : 1
stoichiometry:c30 : 1
stoichiometry:c31 : 1
stoichiometry:c32 : 1
m1583*m1573*m6433*0.1
nodelay
--
0
PMID: 16753195,15229469 The IRAK1?TRAF6 complex then disassociates from the receptor and interacts with another complex consisting of TAK1, TAB1 and TAB2, followed by the phosphorylation and activation of TAK1
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c33 : 1
stoichiometry:c34 : 1
stoichiometry:c35 : 1
m21*m22*0.1
nodelay
--
0
PMID: 16753195,15229469 The IRAK1?TRAF6 complex then disassociates from the receptor and interacts with another complex consisting of TAK1, TAB1 and TAB2, followed by the phosphorylation and activation of TAK1
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c36 : 1
stoichiometry:c37 : 1
m23*0.1
nodelay
--
0
PMID: 16753195,15229469 The IRAK1?TRAF6 complex then disassociates from the receptor and interacts with another complex consisting of TAK1, TAB1 and TAB2, followed by the phosphorylation and activation of TAK1
p14
p14
cso30:i:ME_UnknownActivation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c38 : 1
stoichiometry:c39 : 1
stoichiometry:c40 : 1
m24*m207*0.1
nodelay
--
0
PMID: 16753195 The activated TAK1 subsequently activates the I¦ÊB kinases (IKKs), which phosphorylates I¦ÊB and leads to activation of NF-¦ÊB.
p15
p15
cso30:i:ME_UnknownActivation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c47 : 1
stoichiometry:c48 : 1
stoichiometry:c49 : 1
m24*m29*0.1
nodelay
--
0
PMID: 16753195,10094049,16186825,15229469 Activation of TAK1 also results in the activation of MAPKs, including c-Jun N-terminal kinase (JNK), leading to activation of AP-1
p16
p16
cso30:i:ME_Phosphorylation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c41 : 1
stoichiometry:c42 : 1
stoichiometry:c43 : 1
m25*m186*0.1
nodelay
--
0
PMID: 16753195 The activated TAK1 subsequently activates the I¦ÊB kinases (IKKs), which phosphorylates I¦ÊB and leads to activation of NF-¦ÊB.
p17
p17
cso30:i:ME_UnknownActivation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c44 : 1
stoichiometry:c45 : 1
stoichiometry:c46 : 1
m26*m27*0.1
nodelay
--
0
PMID: 16753195 The activated TAK1 subsequently activates the I¦ÊB kinases (IKKs), which phosphorylates I¦ÊB and leads to activation of NF-¦ÊB.
p15
p18
cso30:i:ME_UnknownActivation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c50 : 1
stoichiometry:c51 : 1
stoichiometry:c52 : 1
m30*m219*0.1
nodelay
--
0
PMID: 16753195,10094049,16186825,15229469 Activation of TAK1 also results in the activation of MAPKs, including c-Jun N-terminal kinase (JNK), leading to activation of AP-1
p19
p19
cso30:i:ME_Binding
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c53 : 1
stoichiometry:c54 : 1
stoichiometry:c55 : 1
m155701*m4923*0.1
nodelay
--
0
PMID: 16753195,11058605,11385577,12527755,12766759,12514169 There is evidence that NOD1 and NOD2 can recognize the core structures of bacterial peptidoglycan in the cytoplasm to activate NF-¦ÊB, which is TLR independent
p1
p2
cso30:i:ME_Binding
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c4 : 1
stoichiometry:c5 : 1
stoichiometry:c6 : 1
m3965*m119368*0.1
nodelay
--
0
PMID:16753195,9851930,11607032 For example, lipopolysaccharide (LPS), a common structure of the cell wall of Gram-negative bacteria, is recognized by TLR4 ; double-stranded RNA (dsRNA), which has long been considered a viral PAMP, triggers TLR3 signaling
p19
p20
cso30:i:ME_Binding
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c56 : 1
stoichiometry:c57 : 1
stoichiometry:c58 : 1
m4947*m155701*0.1
nodelay
--
0
PMID: 16753195,11058605,11385577,12527755,12766759,12514169 There is evidence that NOD1 and NOD2 can recognize the core structures of bacterial peptidoglycan in the cytoplasm to activate NF-¦ÊB, which is TLR independent
p21
p21
cso30:i:ME_UnknownActivation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c59 : 1
stoichiometry:c60 : 1
stoichiometry:c61 : 1
m33*m27*0.1
nodelay
--
0
PMID: 16753195,11058605,11385577,12527755,12766759,12514169 There is evidence that NOD1 and NOD2 can recognize the core structures of bacterial peptidoglycan in the cytoplasm to activate NF-¦ÊB, which is TLR independent
p21
p22
cso30:i:ME_UnknownActivation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c62 : 1
stoichiometry:c63 : 1
stoichiometry:c64 : 1
m32*m27*0.1
nodelay
--
0
PMID: 16753195,11058605,11385577,12527755,12766759,12514169 There is evidence that NOD1 and NOD2 can recognize the core structures of bacterial peptidoglycan in the cytoplasm to activate NF-¦ÊB, which is TLR independent
p23
p23
cso30:i:ME_Binding
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c66 : 1
stoichiometry:c232 : 1
stoichiometry:c67 : 1
m41844*m119368*0.1
nodelay
--
0
PMID: 16753195 Recently, it has been shown that two cytoplasmic RNA helicase proteins, Mda-5 and RIG-I, are sensors of viral dsRNA, which initiate antiviral responses via the adaptor protein VISA/IPS-1/MAVS/Cardif
p23
p24
cso30:i:ME_Binding
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c69 : 1
stoichiometry:c233 : 1
stoichiometry:c70 : 1
m76904*m119368*0.1
nodelay
--
0
PMID: 16753195 Recently, it has been shown that two cytoplasmic RNA helicase proteins, Mda-5 and RIG-I, are sensors of viral dsRNA, which initiate antiviral responses via the adaptor protein VISA/IPS-1/MAVS/Cardif
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c71 : 1
stoichiometry:c72 : 1
stoichiometry:c73 : 1
m35*m68199*0.1
nodelay
--
0
PMID: 16753195 Recently, it has been shown that two cytoplasmic RNA helicase proteins, Mda-5 and RIG-I, are sensors of viral dsRNA, which initiate antiviral responses via the adaptor protein VISA/IPS-1/MAVS/Cardif
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c74 : 1
stoichiometry:c75 : 1
stoichiometry:c76 : 1
m38*m39*0.1
nodelay
--
0
PMID: 16753195,16143103 More recently, it was shown that the glucocorticoid receptor (GR) can selectively transrepress the transcription of a subset of genes (such as Scyb9), of which promoters utilize IRF3 as an essential coactivator of NF-¦ÊB binding to the ¦ÊB sites upon LPS stimulation
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c77 : 1
stoichiometry:c78 : 1
1.0*0.1
nodelay
--
0
PMID: 16753195,16143103 More recently, it was shown that the glucocorticoid receptor (GR) can selectively transrepress the transcription of a subset of genes (such as Scyb9), of which promoters utilize IRF3 as an essential coactivator of NF-¦ÊB binding to the ¦ÊB sites upon LPS stimulation
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c79 : 1
stoichiometry:c80 : 1
m19314*0.1
nodelay
--
0
PMID: 16753195,16143103 For example, both dsRNA and LPS can activate transcription of the IP10 gene
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c81 : 1
stoichiometry:c82 : 1
m5*0.1
nodelay
--
0
PMID: 16753195,16143103 For example, both dsRNA and LPS can activate transcription of the IP10 gene
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c7 : 1
stoichiometry:c8 : 1
stoichiometry:c9 : 1
m19828*m13*0.1
nodelay
--
0
PMID: 16753195,15229469,15207506 Natural or synthetic oligodeoxynucleotides (OND) containing an unmethylated CpG motif (CpG) can activate TLR9, which exclusively couples to the MyD88-dependent pathway
p30
p30
cso30:i:ME_Binding
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c84 : 1
stoichiometry:c83 : 1
stoichiometry:c85 : 1
m18998*m19314*0.1
nodelay
--
0
PMID: 16753195,15229469,15733829 TLR3 signals through myeloid differentiation primary response protein-88 (MyD88)-independent and Toll/interleukin receptor (TIR) domain-containing adaptor-inducing IFN-¦Â (TRIF, also known as TICAM-1)-dependent pathways
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c87 : 1
stoichiometry:c86 : 1
stoichiometry:c88 : 1
m3902*m43*0.1
nodelay
--
0
PMID: 16753195 The adaptor protein TRIF has been demonstrated to interact with the TRAF family-member-associated NF-¦ÊB activator (TANK) binding kinase 1 (TBK1) and IKK¦Å (also known as IKKi) as well as IRF3/7 and thereby to facilitate TBK1 and IKK¦Å to phosphorylate and activate IRF3/7.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c89 : 1
stoichiometry:c90 : 1
stoichiometry:c91 : 1
m43*m1599*0.1
nodelay
--
0
PMID: 16753195 The adaptor protein TRIF has been demonstrated to interact with the TRAF family-member-associated NF-¦ÊB activator (TANK) binding kinase 1 (TBK1) and IKK¦Å (also known as IKKi) as well as IRF3/7 and thereby to facilitate TBK1 and IKK¦Å to phosphorylate and activate IRF3/7.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c92 : 1
stoichiometry:c93 : 1
stoichiometry:c94 : 1
m43*m182*0.1
nodelay
--
0
PMID: 16753195,14739303,16153868 Besides IKK¦Å and TBK1, TRAF6, IKK¦Â and receptor?interactor protein-1 (RIP1) also interact with TRIF
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c95 : 1
stoichiometry:c96 : 1
stoichiometry:c97 : 1
m183*m43*0.1
nodelay
--
0
PMID: 16753195,14739303,16153868 Besides IKK¦Å and TBK1, TRAF6, IKK¦Â and receptor?interactor protein-1 (RIP1) also interact with TRIF
p35
p35
cso30:i:ME_Phosphorylation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c98 : 1
stoichiometry:c99 : 1
stoichiometry:c100 : 1
m45*m977*0.1
nodelay
--
0
PMID: 16753195 The adaptor protein TRIF has been demonstrated to interact with the TRAF family-member-associated NF-¦ÊB activator (TANK) binding kinase 1 (TBK1) and IKK¦Å (also known as IKKi) as well as IRF3/7 and thereby to facilitate TBK1 and IKK¦Å to phosphorylate and activate IRF3/7.
p35
p36
cso30:i:ME_Phosphorylation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c101 : 1
stoichiometry:c102 : 1
stoichiometry:c103 : 1
m44*m977*0.1
nodelay
--
0
PMID: 16753195 The adaptor protein TRIF has been demonstrated to interact with the TRAF family-member-associated NF-¦ÊB activator (TANK) binding kinase 1 (TBK1) and IKK¦Å (also known as IKKi) as well as IRF3/7 and thereby to facilitate TBK1 and IKK¦Å to phosphorylate and activate IRF3/7.
p35
p37
cso30:i:ME_Phosphorylation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c104 : 1
stoichiometry:c105 : 1
stoichiometry:c106 : 1
m45*m980*0.1
nodelay
--
0
PMID: 16753195 The adaptor protein TRIF has been demonstrated to interact with the TRAF family-member-associated NF-¦ÊB activator (TANK) binding kinase 1 (TBK1) and IKK¦Å (also known as IKKi) as well as IRF3/7 and thereby to facilitate TBK1 and IKK¦Å to phosphorylate and activate IRF3/7.
p35
p38
cso30:i:ME_Phosphorylation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c107 : 1
stoichiometry:c108 : 1
stoichiometry:c109 : 1
m44*m980*0.1
nodelay
--
0
PMID: 16753195 The adaptor protein TRIF has been demonstrated to interact with the TRAF family-member-associated NF-¦ÊB activator (TANK) binding kinase 1 (TBK1) and IKK¦Å (also known as IKKi) as well as IRF3/7 and thereby to facilitate TBK1 and IKK¦Å to phosphorylate and activate IRF3/7.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c110 : 1
stoichiometry:c111 : 1
stoichiometry:c112 : 1
m68199*m36*0.1
nodelay
--
0
PMID: 16753195 Recently, it has been shown that two cytoplasmic RNA helicase proteins, Mda-5 and RIG-I, are sensors of viral dsRNA, which initiate antiviral responses via the adaptor protein VISA/IPS-1/MAVS/Cardif
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c10 : 1
stoichiometry:c11 : 1
stoichiometry:c12 : 1
m14*m332813*0.1
nodelay
--
0
PMID: 16753195 Upon stimulation of TLRs, MyD88 is recruited to the TIR domain of TLRs.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c114 : 1
stoichiometry:c113 : 1
stoichiometry:c115 : 1
m19005*m5*0.1
nodelay
--
0
PMID: 16753195,12721283,14519765,14993454,15229469 In addition, two other adaptors, TIR-containing adaptor protein (TIRAP, also known as Mal) and TIR-containing protein (TIRP, also known as TRAM and TICAM-2), participate in those two pathways, respectively
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c116 : 1
stoichiometry:c117 : 1
stoichiometry:c118 : 1
m64*m18998*0.1
nodelay
--
0
PMID: 16753195 TLR4 makes use of both TRIF and MyD88 adaptors to activate IRF3/7, NF-¦ÊB and AP-1 upon the stimulation of LPS.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c119 : 1
stoichiometry:c120 : 1
stoichiometry:c121 : 1
m65*m1599*0.1
nodelay
--
0
PMID: 16753195 The adaptor protein TRIF has been demonstrated to interact with the TRAF family-member-associated NF-¦ÊB activator (TANK) binding kinase 1 (TBK1) and IKK¦Å (also known as IKKi) as well as IRF3/7 and thereby to facilitate TBK1 and IKK¦Å to phosphorylate and activate IRF3/7.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c122 : 1
stoichiometry:c123 : 1
stoichiometry:c124 : 1
m65*m3902*0.1
nodelay
--
0
PMID: 16753195 The adaptor protein TRIF has been demonstrated to interact with the TRAF family-member-associated NF-¦ÊB activator (TANK) binding kinase 1 (TBK1) and IKK¦Å (also known as IKKi) as well as IRF3/7 and thereby to facilitate TBK1 and IKK¦Å to phosphorylate and activate IRF3/7.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c125 : 1
stoichiometry:c126 : 1
stoichiometry:c127 : 1
m65*m182*0.1
nodelay
--
0
PMID: 16753195,14739303,16153868 Besides IKK¦Å and TBK1, TRAF6, IKK¦Â and receptor?interactor protein-1 (RIP1) also interact with TRIF
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c128 : 1
stoichiometry:c129 : 1
stoichiometry:c130 : 1
m65*m69*0.1
nodelay
--
0
PMID: 16753195,14739303,16153868 Besides IKK¦Å and TBK1, TRAF6, IKK¦Â and receptor?interactor protein-1 (RIP1) also interact with TRIF
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c131 : 1
stoichiometry:c132 : 1
stoichiometry:c133 : 1
m43*m69*0.1
nodelay
--
0
PMID: 16753195,14739303,16153868 Besides IKK¦Å and TBK1, TRAF6, IKK¦Â and receptor?interactor protein-1 (RIP1) also interact with TRIF
p35
p47
cso30:i:ME_Phosphorylation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c134 : 1
stoichiometry:c135 : 1
stoichiometry:c136 : 1
m66*m980*0.1
nodelay
--
0
PMID: 16753195 The adaptor protein TRIF has been demonstrated to interact with the TRAF family-member-associated NF-¦ÊB activator (TANK) binding kinase 1 (TBK1) and IKK¦Å (also known as IKKi) as well as IRF3/7 and thereby to facilitate TBK1 and IKK¦Å to phosphorylate and activate IRF3/7.
p35
p48
cso30:i:ME_Phosphorylation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c137 : 1
stoichiometry:c138 : 1
stoichiometry:c139 : 1
m67*m980*0.1
nodelay
--
0
PMID: 16753195 The adaptor protein TRIF has been demonstrated to interact with the TRAF family-member-associated NF-¦ÊB activator (TANK) binding kinase 1 (TBK1) and IKK¦Å (also known as IKKi) as well as IRF3/7 and thereby to facilitate TBK1 and IKK¦Å to phosphorylate and activate IRF3/7.
p35
p49
cso30:i:ME_Phosphorylation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c140 : 1
stoichiometry:c141 : 1
stoichiometry:c142 : 1
m67*m977*0.1
nodelay
--
0
PMID: 16753195 The adaptor protein TRIF has been demonstrated to interact with the TRAF family-member-associated NF-¦ÊB activator (TANK) binding kinase 1 (TBK1) and IKK¦Å (also known as IKKi) as well as IRF3/7 and thereby to facilitate TBK1 and IKK¦Å to phosphorylate and activate IRF3/7.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c13 : 1
stoichiometry:c14 : 1
stoichiometry:c15 : 1
m15*m17258*0.1
nodelay
--
0
PMID: 16753195 MyD88 further recruits IRAK4 to form TLR?MyD88?IRAK4 signal complex.
p35
p50
cso30:i:ME_Phosphorylation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c143 : 1
stoichiometry:c144 : 1
stoichiometry:c145 : 1
m66*m977*0.1
nodelay
--
0
PMID: 16753195 The adaptor protein TRIF has been demonstrated to interact with the TRAF family-member-associated NF-¦ÊB activator (TANK) binding kinase 1 (TBK1) and IKK¦Å (also known as IKKi) as well as IRF3/7 and thereby to facilitate TBK1 and IKK¦Å to phosphorylate and activate IRF3/7.
p51
p51
cso30:i:ME_Binding
cso30:i:CC_Nucleoplasm
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c146 : 1
stoichiometry:c147 : 1
stoichiometry:c149 : 1
stoichiometry:c148 : 1
m37*m69*m1814*0.1
nodelay
--
0
PMID: 16753195,16127453,16153868 For instance, VISA forms a complex with FADD and RIP1 , and it also interacts with TRAF6 in our study
p51
p52
cso30:i:ME_Binding
cso30:i:CC_Nucleoplasm
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c150 : 1
stoichiometry:c151 : 1
stoichiometry:c152 : 1
stoichiometry:c153 : 1
m63*m1814*m69*0.1
nodelay
--
0
PMID: 16753195,16127453,16153868 For instance, VISA forms a complex with FADD and RIP1 , and it also interacts with TRAF6 in our study
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c154 : 1
stoichiometry:c155 : 1
stoichiometry:c156 : 1
m6810*m5*0.1
nodelay
--
0
PMID: 16753195,12721283,14519765,14993454,15229469 In addition, two other adaptors, TIR-containing adaptor protein (TIRAP, also known as Mal) and TIR-containing protein (TIRP, also known as TRAM and TICAM-2), participate in those two pathways, respectively
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c157 : 1
stoichiometry:c158 : 1
stoichiometry:c159 : 1
m332813*m74*0.1
nodelay
--
0
PMID: 16753195 Upon stimulation of TLRs, MyD88 is recruited to the TIR domain of TLRs.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c160 : 1
stoichiometry:c161 : 1
stoichiometry:c162 : 1
m75*m17258*0.1
nodelay
--
0
PMID: 16753195 MyD88 further recruits IRAK4 to form TLR?MyD88?IRAK4 signal complex.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c163 : 1
stoichiometry:c164 : 1
stoichiometry:c165 : 1
m76*m184*0.1
nodelay
--
0
pMID: 16753195 Then the signal complex (TLR?MyD88?IRAK4) recruits IRAK1 and thereby phosphorylates and activates it.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c166 : 1
stoichiometry:c167 : 1
m77*0.1
nodelay
--
0
pMID: 16753195 Then the signal complex (TLR?MyD88?IRAK4) recruits IRAK1 and thereby phosphorylates and activates it.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c168 : 1
stoichiometry:c169 : 1
m78*0.1
nodelay
--
0
PMID: 16753195 The activated IRAK1 autophosphorylates residues in its N-terminus, which leads to recruitment and binding of TRAF6 to the receptor signaling complex
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c170 : 1
stoichiometry:c171 : 1
stoichiometry:c172 : 1
m79*m183*0.1
nodelay
--
0
PMID: 16753195 The activated IRAK1 autophosphorylates residues in its N-terminus, which leads to recruitment and binding of TRAF6 to the receptor signaling complex
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c16 : 1
stoichiometry:c17 : 1
stoichiometry:c18 : 1
m16*m184*0.1
nodelay
--
0
pMID: 16753195 Then the signal complex (TLR?MyD88?IRAK4) recruits IRAK1 and thereby phosphorylates and activates it.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c173 : 1
stoichiometry:c174 : 1
stoichiometry:c175 : 1
m80*0.1
nodelay
--
0
PMID: 16753195,15229469 The IRAK1?TRAF6 complex then disassociates from the receptor and interacts with another complex consisting of TAK1, TAB1 and TAB2, followed by the phosphorylation and activation of TAK1
p61
p61
cso30:i:ME_UnknownActivation
cso30:i:CC_Nucleoplasm
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c176 : 1
stoichiometry:c177 : 1
stoichiometry:c178 : 1
m72*m27*0.1
nodelay
--
0
PMID: 16753195 Both the RIP1/FADD and the TRAF6/TAK1 pathways are sufficient to activate NF-¦ÊB.
p61
p62
cso30:i:ME_UnknownActivation
cso30:i:CC_Nucleoplasm
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c179 : 1
stoichiometry:c180 : 1
stoichiometry:c181 : 1
m73*m27*0.1
nodelay
--
0
PMID: 16753195 Both the RIP1/FADD and the TRAF6/TAK1 pathways are sufficient to activate NF-¦ÊB.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c182 : 1
stoichiometry:c183 : 1
stoichiometry:c184 : 1
m37*m183*0.1
nodelay
--
0
PMID: 16753195,16127453,16153868 For instance, VISA forms a complex with FADD and RIP1 , and it also interacts with TRAF6 in our study
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c185 : 1
stoichiometry:c186 : 1
stoichiometry:c187 : 1
m63*m183*0.1
nodelay
--
0
PMID: 16753195,16127453,16153868 For instance, VISA forms a complex with FADD and RIP1 , and it also interacts with TRAF6 in our study
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c188 : 1
stoichiometry:c189 : 1
stoichiometry:c190 : 1
m82*m1573*0.1
nodelay
--
0
PMID: 16753195 Both the RIP1/FADD and the TRAF6/TAK1 pathways are sufficient to activate NF-¦ÊB.
p61
p66
cso30:i:ME_UnknownActivation
cso30:i:CC_Nucleoplasm
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c191 : 1
stoichiometry:c192 : 1
stoichiometry:c193 : 1
m83*m27*0.1
nodelay
--
0
PMID: 16753195 Both the RIP1/FADD and the TRAF6/TAK1 pathways are sufficient to activate NF-¦ÊB.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c194 : 1
stoichiometry:c195 : 1
stoichiometry:c196 : 1
m81*m1573*0.1
nodelay
--
0
PMID: 16753195 Both the RIP1/FADD and the TRAF6/TAK1 pathways are sufficient to activate NF-¦ÊB.
p61
p68
cso30:i:ME_UnknownActivation
cso30:i:CC_Nucleoplasm
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c197 : 1
stoichiometry:c198 : 1
stoichiometry:c199 : 1
m84*m27*0.1
nodelay
--
0
PMID: 16753195 Both the RIP1/FADD and the TRAF6/TAK1 pathways are sufficient to activate NF-¦ÊB.
p69
p69
cso30:i:ME_UnknownActivation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c200 : 1
stoichiometry:c201 : 1
stoichiometry:c202 : 1
m71*m27*0.1
nodelay
--
0
PMID: 16753195,15064760,16115877 However, there also exist some distinct explanations about the involvement of RIP1 in TRIF-mediated NF-¦ÊB activation. It has been suggested that TRIF interacts with RIP1, and this interaction mediates TLR3-triggered NF-¦ÊB activation
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c19 : 1
stoichiometry:c20 : 1
m17*0.1
nodelay
--
0
pMID: 16753195 Then the signal complex (TLR?MyD88?IRAK4) recruits IRAK1 and thereby phosphorylates and activates it.
p70
p70
cso30:i:ME_Translation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c203 : 1
stoichiometry:c204 : 1
stoichiometry:c205 : 1
m93309*m48*0.1
nodelay
--
0
PMID: 16753195 The TRIF-dependent pathway first stimulates activation of IRF3 leading to production of TNF alpha, which in turn triggers TNFR signaling to activate NF-¦ÊB. PMID: 16753195,16166516 By asking why the activation dynamics of NF-¦ÊB show damped oscillatory behavior when cells are stimulated by tumor necrosis factor alpha (TNF alpha) but stable behavior when stimulated by LPS, however, proposed that the activation of NF-¦ÊB by TRIF-dependent pathway is a result of a secondary response to TNF alpha, which is induced by IRF3 (activated by TLR4/TRIF-mediated pathway in the first response to LPS) and signals through TNF alpha receptor (TNFR)/RIP1 pathway to activate NF-¦ÊB
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c206 : 1
stoichiometry:c207 : 1
stoichiometry:c208 : 1
m230*m85*0.1
nodelay
--
0
PMID: 16753195 The TRIF-dependent pathway first stimulates activation of IRF3 leading to production of TNF alpha, which in turn triggers TNFR signaling to activate NF-¦ÊB. PMID: 16753195,16166516 By asking why the activation dynamics of NF-¦ÊB show damped oscillatory behavior when cells are stimulated by tumor necrosis factor alpha (TNF alpha) but stable behavior when stimulated by LPS, however, proposed that the activation of NF-¦ÊB by TRIF-dependent pathway is a result of a secondary response to TNF alpha, which is induced by IRF3 (activated by TLR4/TRIF-mediated pathway in the first response to LPS) and signals through TNF alpha receptor (TNFR)/RIP1 pathway to activate NF-¦ÊB
p72
p72
cso30:i:ME_UnknownActivation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c209 : 1
stoichiometry:c210 : 1
stoichiometry:c211 : 1
m86*m27*0.1
nodelay
--
0
PMID: 16753195 The TRIF-dependent pathway first stimulates activation of IRF3 leading to production of TNF alpha, which in turn triggers TNFR signaling to activate NF-¦ÊB. PMID: 16753195,16166516 By asking why the activation dynamics of NF-¦ÊB show damped oscillatory behavior when cells are stimulated by tumor necrosis factor alpha (TNF alpha) but stable behavior when stimulated by LPS, however, proposed that the activation of NF-¦ÊB by TRIF-dependent pathway is a result of a secondary response to TNF alpha, which is induced by IRF3 (activated by TLR4/TRIF-mediated pathway in the first response to LPS) and signals through TNF alpha receptor (TNFR)/RIP1 pathway to activate NF-¦ÊB
p73
p73
cso30:i:ME_Phosphorylation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c212 : 1
stoichiometry:c213 : 1
stoichiometry:c214 : 1
m68*m980*0.1
nodelay
--
0
PMID: 16753195 The TLR3 and TLR4 initiated signaling pathways converge at TRIF, which signals through IKK¦Â, IKK¦Å and/or TBK1 for activation of IRF3/7.
p73
p74
cso30:i:ME_Phosphorylation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c215 : 1
stoichiometry:c216 : 1
stoichiometry:c217 : 1
m68*m977*0.1
nodelay
--
0
PMID: 16753195 The TLR3 and TLR4 initiated signaling pathways converge at TRIF, which signals through IKK¦Â, IKK¦Å and/or TBK1 for activation of IRF3/7.
p73
p75
cso30:i:ME_Phosphorylation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c218 : 1
stoichiometry:c219 : 1
stoichiometry:c220 : 1
m46*m980*0.1
nodelay
--
0
PMID: 16753195 The TLR3 and TLR4 initiated signaling pathways converge at TRIF, which signals through IKK¦Â, IKK¦Å and/or TBK1 for activation of IRF3/7.
p73
p76
cso30:i:ME_Phosphorylation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c221 : 1
stoichiometry:c222 : 1
stoichiometry:c223 : 1
m46*m977*0.1
nodelay
--
0
PMID: 16753195 The TLR3 and TLR4 initiated signaling pathways converge at TRIF, which signals through IKK¦Â, IKK¦Å and/or TBK1 for activation of IRF3/7.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c224 : 1
stoichiometry:c225 : 1
m28*0.1
nodelay
--
0
PMID: 16753195 Stimulation of TLRs by PAMPs induces activation and translocation to nucleus of nuclear factor-¦ÊB (NF-¦ÊB), interferon regulatory factor 3/7 (IRF3/7) and/or activator protein-1 (AP-1), which collaborate to induce transcription of various cytokines such as alpha/beta interferon (IFN-alpha/beta), leading to clearance of the infectious pathogens.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c226 : 1
stoichiometry:c227 : 1
m48*0.1
nodelay
--
0
PMID: 16753195 Stimulation of TLRs by PAMPs induces activation and translocation to nucleus of nuclear factor-¦ÊB (NF-¦ÊB), interferon regulatory factor 3/7 (IRF3/7) and/or activator protein-1 (AP-1), which collaborate to induce transcription of various cytokines such as alpha/beta interferon (IFN-alpha/beta), leading to clearance of the infectious pathogens.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c228 : 1
stoichiometry:c229 : 1
m49*0.1
nodelay
--
0
PMID: 16753195 Stimulation of TLRs by PAMPs induces activation and translocation to nucleus of nuclear factor-¦ÊB (NF-¦ÊB), interferon regulatory factor 3/7 (IRF3/7) and/or activator protein-1 (AP-1), which collaborate to induce transcription of various cytokines such as alpha/beta interferon (IFN-alpha/beta), leading to clearance of the infectious pathogens.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c21 : 1
stoichiometry:c22 : 1
m18*0.1
nodelay
--
0
PMID: 16753195 The activated IRAK1 autophosphorylates residues in its N-terminus, which leads to recruitment and binding of TRAF6 to the receptor signaling complex
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c230 : 1
stoichiometry:c231 : 1
m31*0.1
nodelay
--
0
PMID: 16753195 Stimulation of TLRs by PAMPs induces activation and translocation to nucleus of nuclear factor-¦ÊB (NF-¦ÊB), interferon regulatory factor 3/7 (IRF3/7) and/or activator protein-1 (AP-1), which collaborate to induce transcription of various cytokines such as alpha/beta interferon (IFN-alpha/beta), leading to clearance of the infectious pathogens.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c23 : 1
stoichiometry:c24 : 1
stoichiometry:c25 : 1
m183*m19*0.1
nodelay
--
0
PMID: 16753195 The activated IRAK1 autophosphorylates residues in its N-terminus, which leads to recruitment and binding of TRAF6 to the receptor signaling complex
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputInhibitor
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--